NCT05280028View on ClinicalTrials.gov

HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 7, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Menopausal Syndrome
Interventions
DRUG

Tibolone 2.5 mg

Tibolone 2.5 mg per day

DRUG

Estradiol valerate 1 mg/medroxyprogesterone acetate 2.5 mg

Estradiol valerate 1 mg/medroxyprogesterone acetate 2.5 mg per day

Trial Locations (1)

22050

RECRUITING

Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, Banqiao District

All Listed Sponsors
lead

Far Eastern Memorial Hospital

OTHER